Anika Therapeutics Inc. (ANIK) Social Stream
ANIKA THERAPEUTICS INC (ANIK) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ANIK.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-06 | 2 | $46 | $44 | $45 | $22.07 | 103.9% |
| 2021-11-05 | 2 | $48 | $46 | $47 | $22.07 | 112.96% |
| 2021-11-16 | 3 | $55 | $46 | $49.666 | $22.07 | 125.04% |
| 2021-12-01 | 3 | $55.001 | $46 | $49.667 | $22.07 | 125.04% |
| 2022-02-01 | 3 | $50 | $46 | $48 | $22.07 | 117.49% |
| 2022-04-01 | 3 | $46 | $35 | $40.5 | $22.07 | 83.51% |
| 2022-06-06 | 2 | $29 | $29 | $29 | $22.07 | 31.4% |
| 2022-10-14 | 2 | $26 | $26 | $26 | $22.07 | 17.81% |
| 2022-11-01 | 2 | $26.001 | $26.001 | $26.001 | $22.07 | 17.81% |
| 2022-11-09 | 2 | $31 | $26.001 | $28.5 | $22.07 | 29.13% |
| 2023-01-03 | 2 | $31 | $29 | $30 | $22.07 | 35.93% |
| 2023-04-14 | 2 | $31 | $28 | $29.5 | $22.07 | 33.67% |
| 2023-06-01 | 2 | $28 | $28 | $28 | $22.07 | 26.87% |
| 2023-08-10 | 2 | $23 | $23 | $23 | $22.07 | 4.21% |
| 2023-09-21 | 2 | $24 | $23 | $23.5 | $22.07 | 6.48% |
| 2023-12-01 | 2 | $28 | $22 | $25 | $22.07 | 13.28% |
| NA | 2 | $NA | $NA | $NA | $22.07 | NA% |
The Trend in the Analyst Price Target
Over the past 25 months, ANIK's average price target has gone down $22.
ANIK reports an average of 13.22% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-03 | 2 | 31 | 28 | 29.5 | 28.86 | 2.22% |
| 2023-04-14 | 2 | 28 | 28 | 28.0 | 27.72 | 1.01% |
| 2023-06-01 | 2 | 28 | 28 | 28.0 | 26.72 | 4.79% |
| 2023-09-21 | 2 | 24 | 23 | 23.5 | 18.12 | 29.69% |
| 2023-12-01 | 2 | 28 | 22 | 25.0 | 22.66 | 10.33% |
ANIK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
ANIK's average broker recommendation rating improved by 1 over the prior 14 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, ANIKA THERAPEUTICS INC's number of analysts covering the stock is greater than 73.69% of them.
- In terms of how ANIKA THERAPEUTICS INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -31.82% of that group.
- In the context of stocks in the small market cap category, ANIKA THERAPEUTICS INC's average analyst price target is greater than 1295.05% of them.
- In the context of Medical Equipment stocks, ANIKA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 784.85% of them.
In the Medical Equipment industry, ICAD, APYX, and UTMD are the three stocks most similar to ANIKA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ANIK a Buy, Hold or Sell? See the POWR Ratings now!